ERBB2 and breast carcinoma: It has been previously shown, by using a large publicly available clinical breast cancer microarray database, that TIMP-1 expression is associated with poor overall survival (OS) in TNBC patients but not in the entire BC population or in Luminal-A, Luminal-B and HER2+ BC subtypes [25].